Bosch Packaging Technology on Track

PI 7759 PA jm

Global growth expected to continue

· Sights set on peak orders in 2012

· Internationalization and diversification ensure stable growth

· Acquisitions significantly expand portfolio

Stuttgart/Frankfurt am Main - Growth at Bosch Packaging Technology
continues at an above-average rate for the market. The company expects
order books to peak at over 900 million euros in 2012. This will be
accompanied by a twelve percent increase in annual sales. "All of the
available economic data indicates continued growth on a global scale,"
reported Friedbert Klefenz, President of Bosch Packaging Technology,
speaking at Achema in Frankfurt, the industry's leading exhibition for
process technology (booths C70 and C72, hall 3.1). "We expect to see very
dynamic developments in Asia, the Indian subcontinent, Latin America and
Africa - especially in generics, which will significantly gain importance
compared to conventional brand-name drugs."

The international position of Bosch Packaging Technology which currently
generates about 90 percent of its sales outside of Germany, ensures
increasing independence from regional economic fluctuations. At the same
time, diversification in the pharmaceutical sector supports consistent
expansion of the Bosch portfolio along the entire value chain. With the
takeover of Eisai Co., Ltd. (now Eisai Machinery, Tokyo, Japan) in April
2012 and the acquisitions of Hüttlin GmbH (Schopfheim, Germany) and
Manesty (now Bosch Packaging Technology Ltd., Knowsley, United
Kingdom) in summer 2011, Bosch Packaging Technology further expanded
its inspection and process technology portfolio.

New products across the entire value chain at the trade show
Bosch Packaging Technology offers customers a chance to conserve
resources by conducting lab experiments using Bosch machinery. The
subsequent results can be reliably carried over to in-house production
systems. Two complete modular systems for laboratory use are on display
at Achema. Solidlab 1 and 2 are the results of a joint development by
process and technology specialists at Hüttlin and Manesty. One base
assembly accommodates the processing modules used for mixing,
granulating and coating. This significantly lowers investment costs and
reduces space requirements. In Frankfurt Bosch is presenting a complete
process chain with different systems for the production of solid

Achema visitors can also look forward to a complete overview of the Bosch
portfolio of manual, semiautomatic and fully automatic inspection
machines by Eisai Machinery. More than 1,000 of the fully automatic
models are currently in operation around the world. This growth in process
analytic technology enhances the systems in the existing Bosch portfolio.
Developments range from the new, compact KKX 3900 inspection unit
based on soft x-ray technology, to a new Track & Trace solution for mass
serialization. These technologies maximize process reliability and provide
effective protection against tampering and counterfeiting of
pharmaceutical products.

Long-term cooperation with Sartorius Stedim Biotech

Working in the context of a long-term cooperation,
Bosch Packaging Technology is further developing the personalized
medicine segment - drugs that are tailored to small, clearly profiled
groups. This means smaller batch sizes and more frequent system
changeovers while complying with comprehensive hygiene aspects. This is
where the new PreVAS product line jointly developed by
Bosch Packaging Technology and Sartorius Stedim Biotech comes into
play. PreVAS stands for Pre-Validated, Pre-Assembled, Pre-Sterilized
disposable solutions for aseptic filling. The completely pre-validated
disposable filling system for sterile liquid pharmaceuticals significantly
reduces time-to-market and allows unprecedented production flexibility.

100th isolator sold demonstrates extensive system expertise

The 30th Achema exhibition is where Bosch Packaging Technology is
showcasing an array of new products, including the Fast Air Lock ISS 1000
designed for fast, contamination-free transfer of pharmaceutical equipment
into and out of isolators. The company celebrates the sale of the 100th unit
in Frankfurt, confirming many years of experience and expertise in this
segment. For more than 20 years, Bosch Packaging Technology has been
developing isolators for use in the pharmaceutical industry. Compared to
conventional clean-room production systems, isolators ensure higher
product quality, lower operating costs and reliable execution of long
production cycles. Isolator systems are available for all types of machines
used for filling ampoules, vials, cartridges and prefilled syringes.

Expanded service portfolio

The many years of development expertise at Bosch Packaging Technology
go hand in hand with long-term customer support throughout the entire life
cycle of their production systems. This includes support when it comes to
a spare parts inventory (Stock Optimization) and the modernization of
existing systems. It also includes Mavus, a mobile conferencing system
presented in Frankfurt. Mavus consists of a headset with integrated
camera, display, earphones and microphone. The corresponding
rechargeable battery and electronics required for wireless data
transmission are conveniently and safely integrated into a vest. Mavus
enables a customer's technician on-site to make direct audio-visual contact
with Bosch specialists. Within minutes, the technician can handle
troubleshooting as a "guided expert" backed by Bosch technical

Contact person for press inquiries:

Johanna Marquette,

Phone: +41 58 674-7416

Robert Bosch GmbH

Postfach 10 60 50

D-70049 Stuttgart


Phone +41 58 674-7416

Fax +41 58 674-5153

Corporate Communications,

Brand Management, and Sustainability

Senior Vice President: Uta-Micaela Dürig

The Bosch division Packaging Technology, based in Waiblingen (Germany), is one of the
leading suppliers in the field of processing and packaging technology. In more than 15
countries worldwide it develops and produces complete solutions for the pharmaceutical,
food and confectionery industries. The comprehensive service portfolio completes the
package. The worldwide sales and service network offers local contacts. More information

The Bosch Group is a leading global supplier of technology and services. In the areas of
automotive and industrial technology, consumer goods, and building technology, more than
300,000 associates generated sales of 51.5 billion euros in fiscal 2011. The Bosch Group
comprises Robert Bosch GmbH and its roughly 350 subsidiaries and regional companies in
some 60 countries. If its sales and service partners are included, then Bosch is represented
in roughly 150 countries. This worldwide development, manufacturing, and sales network is
the foundation for further growth. Bosch spent some 4.2 billion euros for research and
development in 2011, and applied for over 4,100 patents worldwide. With all its products
and services, Bosch enhances the quality of life by providing solutions which are both
innovative and beneficial.

The company was set up in Stuttgart in 1886 by Robert Bosch (1861-1942) as "Workshop
for Precision Mechanics and Electrical Engineering." The special ownership structure of
Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it
possible for the company to plan over the long term and to undertake significant up-front
investments in the safeguarding of its future. Ninety-two percent of the share capital of
Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The
majority of voting rights are held by Robert Bosch Industrietreuhand KG, an industrial trust.

The entrepreneurial ownership functions are carried out by the trust. The remaining shares
are held by the Bosch family and by Robert Bosch GmbH.
Further information is available online at and

More from Electrical Equipment & Systems

All Topics